Trulieve Cannabis Corp. filings document the regulatory record of a British Columbia cannabis issuer operating as a vertically integrated multi-state operator in the U.S. Recent Form 8-K reports cover operating results, Regulation FD presentations, material definitive agreements, executive compensation matters, and board or officer transitions.
Proxy filings describe annual meeting matters, director elections, executive compensation, equity awards, and shareholder governance. Debt-related filings disclose senior secured notes due 2030, indenture terms, subsidiary guarantees, and related capital-structure obligations tied to Trulieve and its restricted subsidiaries.
Trulieve Cannabis Corp.'s Chief Sales Officer reported an automatic share withholding related to equity compensation. On December 1, 2025, 16,744 subordinate voting shares were disposed of at $5.39 per share under transaction code “F,” which indicates shares withheld to cover tax obligations on vesting restricted stock units. After this tax-related transaction, the officer directly beneficially owned 174,709 subordinate voting shares of Trulieve Cannabis Corp. This filing reflects routine administration of previously granted RSUs rather than an open‑market trade.
Trulieve Cannabis Corp.'s Chief Sales Officer reported an automatic share withholding related to equity compensation. On December 1, 2025, 16,744 subordinate voting shares were disposed of at $5.39 per share under transaction code “F,” which indicates shares withheld to cover tax obligations on vesting restricted stock units. After this tax-related transaction, the officer directly beneficially owned 174,709 subordinate voting shares of Trulieve Cannabis Corp. This filing reflects routine administration of previously granted RSUs rather than an open‑market trade.
Trulieve Cannabis Corp. Chief Legal Officer reports tax-related share withholding
Trulieve Cannabis Corp. officer Eric Powers, the company’s Chief Legal Officer, reported a routine transaction involving the company’s subordinate voting shares. On December 1, 2025, 18,206 subordinate voting shares were withheld at a price of $5.39 per share to cover tax liabilities arising from the vesting of previously granted restricted stock units. This did not represent an open-market sale.
After this withholding, Powers beneficially owns 186,717 subordinate voting shares directly and an additional 1,000 subordinate voting shares indirectly through his spouse. The filing is made on Form 4 and reflects equity compensation and related tax settlement rather than a discretionary trade.
Trulieve Cannabis Corp. Chief Legal Officer reports tax-related share withholding
Trulieve Cannabis Corp. officer Eric Powers, the company’s Chief Legal Officer, reported a routine transaction involving the company’s subordinate voting shares. On December 1, 2025, 18,206 subordinate voting shares were withheld at a price of $5.39 per share to cover tax liabilities arising from the vesting of previously granted restricted stock units. This did not represent an open-market sale.
After this withholding, Powers beneficially owns 186,717 subordinate voting shares directly and an additional 1,000 subordinate voting shares indirectly through his spouse. The filing is made on Form 4 and reflects equity compensation and related tax settlement rather than a discretionary trade.
Trulieve Cannabis Corp. reported an insider equity transaction by its Chief Technology Officer. On December 1, 2025, 18,041 subordinate voting shares were withheld at a price of $5.39 per share to cover tax obligations arising from the vesting of previously granted restricted stock units. After this tax withholding, the reporting person beneficially owns 180,660 subordinate voting shares directly and an additional 7,000 shares indirectly through a spouse. This filing reflects a routine administrative adjustment related to equity compensation rather than an open-market trade.
Trulieve Cannabis Corp. reported an insider equity transaction by its Chief Technology Officer. On December 1, 2025, 18,041 subordinate voting shares were withheld at a price of $5.39 per share to cover tax obligations arising from the vesting of previously granted restricted stock units. After this tax withholding, the reporting person beneficially owns 180,660 subordinate voting shares directly and an additional 7,000 shares indirectly through a spouse. This filing reflects a routine administrative adjustment related to equity compensation rather than an open-market trade.
Trulieve Cannabis Corp. reported an insider equity transaction by its Chief Production Officer on a Form 4. On December 1, 2025, 18,359 subordinate voting shares were withheld at a price of $5.39 per share to cover tax obligations arising from the vesting of previously granted restricted stock units. After this tax‑withholding event, the reporting person beneficially owned 200,182 subordinate voting shares directly. This filing reflects routine equity compensation and related tax settlement rather than an open-market purchase or sale.
Trulieve Cannabis Corp. reported an insider equity transaction by its Chief Production Officer on a Form 4. On December 1, 2025, 18,359 subordinate voting shares were withheld at a price of $5.39 per share to cover tax obligations arising from the vesting of previously granted restricted stock units. After this tax‑withholding event, the reporting person beneficially owned 200,182 subordinate voting shares directly. This filing reflects routine equity compensation and related tax settlement rather than an open-market purchase or sale.
Trulieve Cannabis Corp. Chairman and CEO Kim Rivers reported a routine insider transaction related to equity compensation. On December 1, 2025, 63,237 Subordinate Voting Shares were withheld at $5.39 per share to cover tax obligations arising from the vesting of previously granted restricted stock units. After this withholding, she beneficially owned 2,137,170 Subordinate Voting Shares directly.
The filing also notes additional holdings, including Multiple Voting Shares and vested stock options. As of this report, Rivers is listed as a Director, 10% owner, Chairman and CEO, and the filing is made by a single reporting person.
Trulieve Cannabis Corp. Chairman and CEO Kim Rivers reported a routine insider transaction related to equity compensation. On December 1, 2025, 63,237 Subordinate Voting Shares were withheld at $5.39 per share to cover tax obligations arising from the vesting of previously granted restricted stock units. After this withholding, she beneficially owned 2,137,170 Subordinate Voting Shares directly.
The filing also notes additional holdings, including Multiple Voting Shares and vested stock options. As of this report, Rivers is listed as a Director, 10% owner, Chairman and CEO, and the filing is made by a single reporting person.
Trulieve Cannabis Corp. disclosed an insider equity transaction by its Chief Accounting Officer on a Form 4. On December 1, 2025, the officer had 7,850 subordinate voting shares withheld at a price of $5.39 per share. The filing explains that these shares were withheld to cover tax liabilities arising from the vesting of previously granted restricted stock units (RSUs), rather than being sold in an open-market trade. Following this administrative tax-withholding event, the officer reports beneficial ownership of 74,289 subordinate voting shares, held directly.
Trulieve Cannabis Corp. disclosed an insider equity transaction by its Chief Accounting Officer on a Form 4. On December 1, 2025, the officer had 7,850 subordinate voting shares withheld at a price of $5.39 per share. The filing explains that these shares were withheld to cover tax liabilities arising from the vesting of previously granted restricted stock units (RSUs), rather than being sold in an open-market trade. Following this administrative tax-withholding event, the officer reports beneficial ownership of 74,289 subordinate voting shares, held directly.
Trulieve Cannabis Corp.'s president filed a Form 4 reporting an automatic share withholding tied to equity compensation. On December 1, 2025, 7,009 Subordinate Voting Shares were withheld at $5.39 per share to cover taxes due upon the vesting of previously granted restricted stock units. After this tax withholding, the reporting person directly owns 523,201 Subordinate Voting Shares.
The filing also notes indirect holdings of 22,635 Multiple Voting Shares in one trust and 22,636 Multiple Voting Shares in another trust, over which the reporting person may be deemed to have voting and investment control. These Multiple Voting Shares are convertible into Subordinate Voting Shares on a one-for-100 basis, representing an aggregate of 4,527,100 Subordinate Voting Shares.
Trulieve Cannabis Corp.'s president filed a Form 4 reporting an automatic share withholding tied to equity compensation. On December 1, 2025, 7,009 Subordinate Voting Shares were withheld at $5.39 per share to cover taxes due upon the vesting of previously granted restricted stock units. After this tax withholding, the reporting person directly owns 523,201 Subordinate Voting Shares.
The filing also notes indirect holdings of 22,635 Multiple Voting Shares in one trust and 22,636 Multiple Voting Shares in another trust, over which the reporting person may be deemed to have voting and investment control. These Multiple Voting Shares are convertible into Subordinate Voting Shares on a one-for-100 basis, representing an aggregate of 4,527,100 Subordinate Voting Shares.
Trulieve Cannabis Corp. (TCNNF): Director equity grants reported. On 11/04/2025, a director reported receiving 11,329 subordinate voting shares via a grant of restricted stock units at a stated price of $0. Following the grant, beneficial ownership of subordinate voting shares was 11,329, held directly.
The filing also reports an award of stock options for 18,859 subordinate voting shares with an exercise price of $6.62; the options are fully vested. The RSUs vest on the earliest of the end of board service, a change of control, or December 1, 2031.
Trulieve Cannabis Corp. filed its Q3 2025 report, posting revenue of $288.2 million and a net loss of $28.8 million. Gross margin was 58.9%, and SG&A fell sharply as political contributions declined year over year. Despite positive operating income, a high tax provision drove bottom-line losses.
Liquidity remained strong with cash and cash equivalents of $449.2 million at quarter end. Year-to-date, operating cash flow was $213.6 million, and Adjusted EBITDA reached $102.7 million in Q3. Uncertain tax position liabilities were $616.3 million, reflecting ongoing tax disputes disclosed by the company. Subsequent event: Trulieve issued a notice of redemption for all outstanding 8% 2026 Notes, totaling $368.0 million, at par plus accrued interest, with a scheduled redemption date of December 5, 2025.
Trulieve Cannabis Corp. furnished an update on its business. The company announced its results for the three and nine months ended September 30, 2025 via a press release and provided an investor slide deck for conference use. Both materials are dated November 5, 2025 and were submitted as Exhibits 99.1 and 99.2. The company noted these materials are furnished, not filed, and therefore are not subject to Section 18 liability.